These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

548 related articles for article (PubMed ID: 28273820)

  • 1. In Vitro Activities of LCB 01-0648, a Novel Oxazolidinone, against Gram-Positive Bacteria.
    Oh SH; Kim J; Baek SY; Chae SE; Park HS; Cho YL; Kwak JH
    Molecules; 2017 Mar; 22(3):. PubMed ID: 28273820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibacterial activity of LCB01-0062, a novel oxazolidinone.
    Jung SJ; Yun IN; Park HS; Lee HH; Jeong JW; Kim YZ; Cho YL; Kwak JH
    Int J Antimicrob Agents; 2012 Dec; 40(6):539-43. PubMed ID: 23058227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In Vivo Activity of LCB 01-0699, a Prodrug of LCB 01-0648, against Staphylococcus aureus.
    Oh SH; Park HS; Lee JH; Baek SY; Chae SE; Oh K; Cho YL; Kwak JH
    Molecules; 2017 Nov; 22(12):. PubMed ID: 29186032
    [No Abstract]   [Full Text] [Related]  

  • 4. Synthesis and antibacterial activity of some aryloxy/thioaryloxy oxazolidinone derivatives.
    Arora V; Salunkhe MM; Sinha N; Sinha RK; Jain S
    Bioorg Med Chem Lett; 2004 Sep; 14(18):4647-50. PubMed ID: 15324881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In Vitro and In Vivo Activities of a Bi-Aryl Oxazolidinone, RBx 11760, against Gram-Positive Bacteria.
    Barman TK; Kumar M; Mathur T; Chaira T; Ramkumar G; Kalia V; Rao M; Pandya M; Yadav AS; Das B; Upadhyay DJ; Hamidullah ; Konwar R; Raj VS; Singh H
    Antimicrob Agents Chemother; 2016 Dec; 60(12):7134-7145. PubMed ID: 27645240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and antibacterial activity of a series of alpha-substituted acetylpiperazinyl oxazolidinones.
    Wang XJ; Du GJ; Zhao SQ; Yan M; Gu LQ
    Chem Biol Drug Des; 2009 Sep; 74(3):276-81. PubMed ID: 19703029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro and in vivo activities of LCB01-0371, a new oxazolidinone.
    Jeong JW; Jung SJ; Lee HH; Kim YZ; Park TK; Cho YL; Chae SE; Baek SY; Woo SH; Lee HS; Kwak JH
    Antimicrob Agents Chemother; 2010 Dec; 54(12):5359-62. PubMed ID: 20855730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and antibacterial activity of 5-substituted oxazolidinones.
    Phillips OA; Udo EE; Ali AA; Al-Hassawi N
    Bioorg Med Chem; 2003 Jan; 11(1):35-41. PubMed ID: 12467705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and antibacterial activities of N-substituted-glycinyl 1H-1,2,3-triazolyl oxazolidinones.
    Phillips OA; Udo EE; Abdel-Hamid ME; Varghese R
    Eur J Med Chem; 2013 Aug; 66():246-57. PubMed ID: 23811087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conformational constraint in oxazolidinone antibacterials. Synthesis and structure-activity studies of (azabicyclo[3.1.0]hexylphenyl)oxazolidinones.
    Renslo AR; Jaishankar P; Venkatachalam R; Hackbarth C; Lopez S; Patel DV; Gordeev MF
    J Med Chem; 2005 Jul; 48(15):5009-24. PubMed ID: 16033280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxazolidinone-containing Hybrids with Antibacterial Activity against Methicillin-resistant Staphylococcus aureus (MRSA): A Mini-review.
    Jiang D; Liu B; Gao T
    Curr Top Med Chem; 2021; 21(27):2440-2454. PubMed ID: 33185161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and in vitro evaluation of substituted phenyl-piperazinyl-phenyl oxazolidinones against Gram-positive bacteria.
    Liu J; He B; Yu A; Zhou W
    Chem Biol Drug Des; 2007 Apr; 69(4):265-8. PubMed ID: 17461974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro activity of retapamulin against linezolid and methicillin-resistant Staphylococcus aureus isolates.
    Candel FJ; Morales G; Picazo JJ
    Rev Esp Quimioter; 2011 Sep; 24(3):127-30. PubMed ID: 21947094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro activity of linezolid and other antibiotics against Gram-positive bacteria from the major teaching hospitals in Kuwait.
    Al Sweih N; Mokaddas E; Jamal W; Phillips OA; Rotimi VO
    J Chemother; 2005 Dec; 17(6):607-13. PubMed ID: 16433190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel oxazolidinone-quinolone hybrid antimicrobials.
    Gordeev MF; Hackbarth C; Barbachyn MR; Banitt LS; Gage JR; Luehr GW; Gomez M; Trias J; Morin SE; Zurenko GE; Parker CN; Evans JM; White RJ; Patel DV
    Bioorg Med Chem Lett; 2003 Dec; 13(23):4213-6. PubMed ID: 14623004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and antibacterial activity of novel (un)substituted benzotriazolyl oxazolidinone derivatives.
    Dixit PP; Nair PS; Patil VJ; Jain S; Arora SK; Sinha N
    Bioorg Med Chem Lett; 2005 Jun; 15(12):3002-5. PubMed ID: 15908210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An evolved oxazolidinone with selective potency against Mycobacterium tuberculosis and gram positive bacteria.
    Kaushik A; Heuer AM; Bell DT; Culhane JC; Ebner DC; Parrish N; Ippoliti JT; Lamichhane G
    Bioorg Med Chem Lett; 2016 Aug; 26(15):3572-6. PubMed ID: 27329794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antimicrobial resistance trends among 5608 clinical Gram-positive isolates in China: results from the Gram-Positive Cocci Resistance Surveillance program (2005-2010).
    Zhao C; Sun H; Wang H; Liu Y; Hu B; Yu Y; Sun Z; Chu Y; Cao B; Liao K; Lei J; Hu Z; Zhang L; Zhang X; Xu Y; Wang Z; Chen M
    Diagn Microbiol Infect Dis; 2012 Jun; 73(2):174-81. PubMed ID: 22521693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel and potent oxazolidinone antibacterials featuring 3-indolylglyoxamide substituents.
    Takhi M; Singh G; Murugan C; Thaplyyal N; Maitra S; Bhaskarreddy KM; Amarnath PV; Mallik A; Harisudan T; Trivedi RK; Sreenivas K; Selvakumar N; Iqbal J
    Bioorg Med Chem Lett; 2008 Sep; 18(18):5150-5. PubMed ID: 18768315
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and biological evaluation of benzazepine oxazolidinone antibacterials.
    Johnson PD; Aristoff PA; Zurenko GE; Schaadt RD; Yagi BH; Ford CW; Hamel JC; Stapert D; Moerman JK
    Bioorg Med Chem Lett; 2003 Dec; 13(23):4197-200. PubMed ID: 14623000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.